Tag: sale

ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, today announced the pricing of 22 million ordinary shares, par value $0.0001 per share, of the Company (the “Placement Shares”), at a price of HKD68.60 per share, in the offering by Dajun Yang Dynasty Trust, an affiliate of the Company’s Chief Executive Officer, Dajun Yang, M.D., Ph.D. (the “Vendor”) in an offshore transaction outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act of 1933, as amended (the “Securities Act”)(the “Offshore Placement”), for aggregate gross proceeds of approximately HKD1,509.2 million (or approximately US$192.3 million based on exchange rate of 1 USD to 7.85 HKD), before deducting placing fees and other offering expenses. The Offshore Placement, which was oversubscribed by eight times, is expected to close on July 17, 2025.

NAPLES, FL, July 14, 2025 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) and its wholly owned subsidiary, Pro Music Rights, were recently featured in Bloomberg News and the Los Angeles Times in connection with national coverage on the rising costs and growing complexity of music licensing for restaurants and bars. The coverage highlights Pro Music Rights as a leading innovator among performance rights organizations (PROs), positioned to modernize an industry long dominated by legacy structures.

NEW CANAAN, Conn., July 14, 2025 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that it plans to host a conference call and report its financial results for the second quarter ended June 30, 2025 on Thursday, August 7, 2025. Additional details are available under the Investor Relations section of the Company’s website: https://ir.newlake.com/.

SALT LAKE CITY, July 14, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, has completed the Company’s previously announced sale of PIEPS and assets of the JetForce avalanche pack intellectual property to a private investment firm for a total purchase price of €7.8 million, or approximately $9.1 million, including cash and debt.

Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasury